--- title: "LogicMark, Inc. (LGMK.US)" type: "quote" locale: "en" url: "https://longbridge.com/en/quote/LGMK.US.md" symbol: "LGMK.US" name: "LogicMark, Inc." industry: "Health Care Equipment" --- # LogicMark, Inc. (LGMK.US) | Item | Detail | |------|--------| | Industry | Health Care Equipment | | Location | US Market | | Website | [www.logicmark.com](https://www.logicmark.com) | ## Company Profile LogicMark, Inc. provides personal emergency response systems (PERS), health communications devices, and Internet of Things (IoT) technology that creates a connected care platform in the United States. The Company’s PERS devices incorporate two-way voice communication technology directly in the medic... ## Financial Score > *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.* > Updated: 2026-02-15T04:30:13.000Z **Overall: C (0.44)** **Industry**: Health Care Equipment | Metric | Value | |--------|-------| | Industry Ranking | 107 / 184 | | Industry Median | C | | Industry Average | C | - **Style**: Value - Stocks where the company's main business is in a mature stage. - **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns. ### Score Analysis **Style Score**: #### Growth Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | 5.27% | | | Net Profit YoY | 42.80% | | #### Value Score: | Indicator | Value | Rating | |-----------|-------|--------| | P/B Ratio | 0.04 | | | Dividend Ratio | 0.00% | | **Size Score**: #### Market Cap Score: | Indicator | Value | Rating | |-----------|-------|--------| | Market Cap | 634245.50 | | #### Revenue Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue | 10.61M | | **Multi Score**: C #### Profit Score: D | Indicator | Value | Rating | |-----------|-------|--------| | ROE | -60.15% | E | | Profit Margin | -90.21% | E | | Gross Margin | 65.83% | A | #### Growth Score: B | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | 5.27% | C | | Net Profit YoY | 42.80% | B | | Total Assets YoY | 39.46% | A | | Net Assets YoY | 38.69% | A | #### Cash Score: C | Indicator | Value | Rating | |-----------|-------|--------| | Cash Flow Margin | -119.37% | D | | OCF YoY | 5.27% | C | #### Operating Score: C | Indicator | Value | Rating | |-----------|-------|--------| | Turnover | 0.55 | C | #### Debt Score: A | Indicator | Value | Rating | |-----------|-------|--------| | Gearing Ratio | 12.21% | A | ```chart-data:radar { "title": "Longbridge Financial Score - LogicMark, Inc.", "chart_type": "radar", "dimensions": [ { "name": "Profit", "grade": "D", "indicators": [ { "name": "ROE", "value": "-60.15%", "rating": "E" }, { "name": "Profit Margin", "value": "-90.21%", "rating": "E" }, { "name": "Gross Margin", "value": "65.83%", "rating": "A" } ] }, { "name": "Growth", "grade": "B", "indicators": [ { "name": "Revenue YoY", "value": "5.27%", "rating": "C" }, { "name": "Net Profit YoY", "value": "42.80%", "rating": "B" }, { "name": "Total Assets YoY", "value": "39.46%", "rating": "A" }, { "name": "Net Assets YoY", "value": "38.69%", "rating": "A" } ] }, { "name": "Cash", "grade": "C", "indicators": [ { "name": "Cash Flow Margin", "value": "-119.37%", "rating": "D" }, { "name": "OCF YoY", "value": "5.27%", "rating": "C" } ] }, { "name": "Operating", "grade": "C", "indicators": [ { "name": "Turnover", "value": "0.55", "rating": "C" } ] }, { "name": "Security", "grade": "A", "indicators": [ { "name": "Gearing Ratio", "value": "12.21%", "rating": "A" } ] } ] } ``` ### Peer Comparison | Rank | Name | Profit | Growth | Operation | Security | Cash | Rating | |------|------|--------|--------|-----------|----------|------|--------| | 01 | Inspire Medical (US.INSP) | A | B | A | A | B | A | | 02 | Delcath (US.DCTH) | C | A | A | A | A | A | | 03 | Intuitive Surgical (US.ISRG) | A | B | C | A | B | B | | 04 | Stryker (US.SYK) | A | B | C | C | B | B | | 05 | Boston Scientific (US.BSX) | B | B | E | A | B | B | ## Valuation Analysis | Metric | Current | Industry Ranking | High | Median | Low | |--------|---------|-----------------|------|--------|-----| | PE (TTM) | -0.07 | 51/181 | - | - | - | | PB | 0.04 | 1/181 | 0.11 | 0.09 | 0.04 | | PS (TTM) | 0.06 | 7/181 | 0.20 | 0.17 | 0.06 | | Dividend Yield | 0.00% | - | - | - | - | ## Institutional View ### Analyst Rating Distribution > As of 2025-11-18T05:00:00.000Z Total Analysts: **1** | Rating | Count | Percentage | |--------|-------|-----------| | Buy | 0 | 0% | | Overweight | 0 | 0% | | Hold | 0 | 0% | | Underweight | 0 | 0% | | Sell | 0 | 0% | ### Target Price Forecast | Metric | Price | |--------|-------| | Current Price | 0.70 | | Highest Target | 2.10 | | Lowest Target | 2.10 | ## References - [Company Overview](https://longbridge.com/en/quote/LGMK.US/overview.md) - Shareholders, executives, business segments - [Financials](https://longbridge.com/en/quote/LGMK.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan - [Topics & Discussions](https://longbridge.com/en/quote/LGMK.US/topics.md) - Community topics and discussions --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.